Ablative allogeneic hematopoietic cell transplantation in adults 60 years of age and older.

Wallen, Herschel; Gooley, Theodore A; Deeg, H Joachim; Pagel, John M; Press, Oliver W; Appelbaum, Frederick R; Storb, Rainer; Gopal, Ajay K

Wallen, Herschel; Gooley, Theodore A; Deeg, H Joachim; Pagel, John M; Press, Oliver W; Appelbaum, Frederick R; Storb, Rainer; Gopal, Ajay K.

Affiliation

Wallen H; Clinical Research Division, Fred Hutchinson Cancer Research Center, University of Washington, 1100 Fairview Ave N, D3-100, Seattle, WA 98109, USA. hwallen@u.washington.edu

J Clin Oncol ; 23(15): 3439-46, 2005 May 20.

Article in En | MEDLINE | ID: mdl-15824415

Subject(s)

Hematologic Neoplasms/diagnosis; Hematologic Neoplasms/therapy; Hematopoietic Stem Cell Transplantation/methods; Transplantation Conditioning/methods; Age Factors; Aged; Confidence Intervals; Female; Graft Survival; Hematologic Neoplasms/mortality; Hematopoietic Stem Cell Transplantation/adverse effects; Humans; Male; Middle Aged; Probability; Prognosis; Proportional Hazards Models; Registries; Retrospective Studies; Risk Assessment; Survival Rate; Transplantation, Homologous; Treatment Outcome

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Hematopoietic Stem Cell Transplantation / Hematologic Neoplasms / Transplantation Conditioning Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: J Clin Oncol Year: 2005 Type: Article Affiliation country: United States

Search on Google

XML

PubMed Links